Definitive Contract N6264517C4029

Award Date 9/28/17
Potential Completion Date 4/30/18
Potential Value $397K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Navy Bureau of Medicine and Surgery awarded a $102,344 firm-fixed-price purchase order to Biofire Defense LLC for FILMARRAY RESP PANELS 2.1. The contract has an ultimate completion date of September 30, 2025. Biofire Defense LLC is a for-profit limited liability company that manufactures biological agent identification products, including the FilmArray system, for defense and public health applications. This award is not associated with a set-aside designation. Biofire Defense LLC has...
This is a fixed-price purchase order awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a manufacturer of biological agent identification products including the Biofire FilmArray system. The $147,187.63 contract is for the provision of Film Array Equipment #1, with a performance period ending on December 8, 2016. Biofire Defense LLC is a for-profit limited liability company that has previously received federal prime contracts and grants related to biological threat...
This firm fixed-price purchase order was awarded by the Bureau of Medicine and Surgery, a defense agency within the U.S. Department of the Navy, to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $69,801.94 contract is for the delivery of FilmArray Respiratory Panels 2.1, a diagnostic assay used to detect respiratory pathogens. The award has a completion date of September 30, 2025 and does not utilize a set-aside...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed-price purchase order to Biofire Defense LLC for the FILMARRAY 2.0 COMPLETE, COVID-19 ECM KIT. The $102,586.80 contract was awarded on April 28, 2020 with a completion date of November 30, 2020. Biofire Defense is a for-profit limited liability company that manufactures goods, including biological agent identification products and COVID-19 test kits, for federal agencies. This award is not associated with a larger...
This firm-fixed-price purchase order was awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Biofire Defense LLC, a for-profit limited liability company based in Salt Lake City, Utah. The contract is for the delivery of Biofire FilmArray 2.0 complete systems, a molecular diagnostic technology used for rapid pathogen detection and infectious disease testing. The contract has a ceiling value of $39,206.77 and a period of performance ending on April 24, 2020. This contract award is...
This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods. The $48,748.00 firm fixed price purchase order is for the delivery of a Respiratory Panel 2.1 IVD with 30 tests. The contract has an ultimate completion date of March 11, 2025. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems,...
This federal contract award was made by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that specializes in biological agent identification products. The $19,810.72 firm fixed-price purchase order is for the delivery of FILM ARRAY GASTROINTENSTINAL PANELS. This award is not associated with a set-aside program. Biofire Defense has a history of providing diagnostic assays, test kits, and testing platforms like the...
This federal contract award to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products, is for the delivery of FilmArray 2.0 diagnostic systems, GI panel test kits, and respiratory panel test kits to the U.S. Navy Bureau of Medicine and Surgery. The contract is a firm fixed-price purchase order with a ceiling value of $148,173.60 and a period of performance through September 29, 2017. There is no set-aside designation for this award. Biofire...
This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of a FILMARRAY RESP PANEL product, with a potential value of $109,632.24. The contract is a Delivery Order issued under Biofire's existing Multiple Award Schedule (MAS) contract with the federal government. The work will be performed in Salt Lake...
This is a $90,878.59 firm fixed price delivery order awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for the delivery of Film Array kits, including the GI Panel, Bio Threat E, and FAIV Kits, which support respiratory infection testing. The contract has no set-aside designation and was issued under the Multiple Award Schedule (MAS) contract vehicle....

This is a definitive contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of Biofire's FILM ARRAY 2.0 MULTIPLEX PCR system, a fully integrated diagnostic platform, for a firm fixed price of $396,851.60. The work will be performed in Parsippany, New Jersey, and the contract has a completion date of April 30, 2018. This award does not have a set-aside designation. Biofire Defense has previously received other federal contract and grant awards from the Department of Defense, Department of State, National Institutes of Health, and Department of Health and Human Services for the provision of biological detection and infectious disease testing capabilities, including support for the COVID-19 response.

Generated 3/21/24, 9:38 PM